Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/4/2025

Treatment of Impetigo

Introduction to Impetigo Treatment

  • The American College of Physicians recommends topical mupirocin as the first-line treatment for localized impetigo, while oral antibiotics are recommended for extensive disease or when topical therapy is impractical 1
  • Lesions typically occur on exposed areas of the body, particularly face and extremities 2

Treatment Algorithm

  • Topical therapy is preferred for limited disease due to fewer systemic side effects 3
  • Mupirocin 2% ointment applied three times daily for 5-7 days is the preferred topical treatment 1
  • Oral antibiotics should be used when impetigo is extensive or involves multiple sites 1
  • Oral antibiotics should be used when topical therapy is impractical 3
  • Dicloxacillin: 250 mg four times daily for adults is recommended for presumed methicillin-susceptible S. aureus (MSSA) 1, 3
  • Cephalexin: 250-500 mg four times daily for adults is recommended for presumed methicillin-susceptible S. aureus (MSSA) 1, 3
  • Clindamycin: 300-450 mg three times daily for adults is recommended for suspected or confirmed MRSA 1, 3

Important Clinical Considerations

  • Penicillin alone is not effective for impetigo as it lacks adequate coverage against S. aureus 1, 3
  • Duration of therapy: 5-7 days for topical treatment and 5-10 days for oral antibiotics 1
  • Obtain cultures from lesions if there is treatment failure, MRSA is suspected, or in cases of recurrent infections 1
  • Keep lesions covered with clean, dry bandages and maintain good personal hygiene to prevent spread 1

Special Populations

  • For pregnant patients, cephalexin is generally considered safe 1, 3
  • Avoid tetracyclines (doxycycline, minocycline) in children under 8 years and pregnant women 1, 3
  • For pediatric patients, dosing should be adjusted appropriately, such as dicloxacillin: 12 mg/kg/day in 4 divided doses 3

Monitoring and Follow-up

  • Re-evaluate if no improvement after 48-72 hours of therapy 3
  • Consider alternative diagnosis if presentation is atypical or not responding to appropriate therapy 3

REFERENCES

1

Treatment of Impetigo on Hand Lesions [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Treatment of Impetigo Refractory to Mupirocin [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025